Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastro-oesophageal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01582906
What this trial is testing

A Survivorship Care Plan for Gynaecological Cancer Patients

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionCervical CancerEndometrial Cancer+7 more
Royal Marsden NHS Foundation Trust 150
Not applicableStudy completedNCT03719716
What this trial is testing

Early Support in Primary Care for People Starting Treatment for Cancer

Who this might be right for
Cancer of PancreasCancer of StomachCancer of Esophagus
NHS Lothian 46
Not applicableStudy completedNCT03528629
What this trial is testing

IMAB362 in Japanese Subjects With Locally Advanced or Metastatic Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma

Who this might be right for
Gastric CancerGastro-esophageal Junction (GEJ) Cancer
Astellas Pharma Inc 18
Not applicableLooking for participantsNCT06713421
What this trial is testing

Effect of Premedication With Pronase on Mucosal Cleanliness During EGD

Who this might be right for
Esophageal CancerGastric Cancer
Changhai Hospital 3,000
Large-scale testing (Phase 3)Study completedNCT00680901
What this trial is testing

LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib

Who this might be right for
Neoplasms, Gastrointestinal Tract
Novartis Pharmaceuticals 545
Not applicableEnded earlyNCT02457299
What this trial is testing

Esophagectomy With or Without Prior Ischemic Gastric Preconditioning

Who this might be right for
Esophageal Cancer
Endeavor Health 1
Not applicableStudy completedNCT05266300
What this trial is testing

Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines.

Who this might be right for
Adverse Drug EventColon CancerBreast Cancer+5 more
University of Southern Denmark 722
Post-approval studies (Phase 4)Looking for participantsNCT05183126
What this trial is testing

Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer

Who this might be right for
Breast CancerMetastatic Gastric CancerEsophageal Cancer
University of Michigan Rogel Cancer Center 22
Not applicableStudy completedNCT00342654
What this trial is testing

Nutrition Intervention Trials in Linxian Follow-up Study

Who this might be right for
Esophageal CancerGastric Cancer
National Cancer Institute (NCI) 32,902
Testing effectiveness (Phase 2)Study completedNCT00264433
What this trial is testing

The Safety and Effects of ADH-1 Given Intravenously as a Single Agent

Who this might be right for
Neoplasms
Adherex Technologies, Inc.
Not applicableUnknownNCT01979549
What this trial is testing

Adverse Events During Upper Gastrointestinal Endoscopy

Who this might be right for
Patients Need Upper Gastrointestinal EndoscopyPeptic UlcerGastric Cancer+2 more
RenJi Hospital 6,000
Testing effectiveness (Phase 2)Looking for participantsNCT06172478
What this trial is testing

HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorMelanomaHead and Neck Cancer+11 more
Daiichi Sankyo 740
Large-scale testing (Phase 3)Study completedNCT00678535
What this trial is testing

Erbitux in Combination With Xeloda and Cisplatin in Advanced Esophago-gastric Cancer

Who this might be right for
Gastric Cancer
Merck KGaA, Darmstadt, Germany 904
Not applicableActive Not RecruitingNCT05899985
What this trial is testing

Magnetic Sentinel Lymph Node Mapping in Upper Gastro-Intestinal Cancer: A Feasibility Clinical Investigation

Who this might be right for
Gastric CancerEsophageal Cancer
Ferronova Pty Ltd 60
Not applicableLooking for participantsNCT00899626
What this trial is testing

Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients

Who this might be right for
Colorectal CancerEsophageal CancerGastric Cancer+2 more
Vanderbilt University Medical Center 5,000
Testing effectiveness (Phase 2)Study completedNCT00397904
What this trial is testing

Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and Cisplatin

Who this might be right for
Esophageal CancerGastric Cancer
Memorial Sloan Kettering Cancer Center 16
Not applicableActive Not RecruitingNCT00582647
What this trial is testing

Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract

Who this might be right for
Esophageal CancerBile Duct NeoplasmsGastric Cancer+4 more
Memorial Sloan Kettering Cancer Center 6,000
Not applicableStudy completedNCT00310115
What this trial is testing

Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy

Who this might be right for
Bladder CancerCervical CancerEsophageal Cancer+8 more
M.D. Anderson Cancer Center 469
Testing effectiveness (Phase 2)Active Not RecruitingNCT05713838
What this trial is testing

Organ Preservation With Durvalumab-based Immunotherapy in Combination With Chemoradiation as Definitive Therapy for Early Stage Esophageal Adenocarcinoma With Indication for Radical Surgery

Who this might be right for
Esophagus Adenocarcinoma
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 32
Testing effectiveness (Phase 2)Study completedNCT00003192
What this trial is testing

Aminocamptothecin in Treating Patients With Stomach Cancer or Cancer of the Esophagus

Who this might be right for
Esophageal CancerGastric Cancer
University of Chicago 15
Next Page